Heterogeneity in plasminogen activator (PA) levels in human prostate cancer cell lines: increased PA activity correlates with biologically aggressive behavior

Prostate. 1991;18(3):201-14. doi: 10.1002/pros.2990180303.

Abstract

Plasminogen activators (PA), particularly the lower Mr urokinase (u-PA) type, have been associated with tumor cell invasion and metastasis. We have examined the expression of PA by two human prostate cancer cell lines (PC-3 and DU-145) using functional and immunologic techniques. The culture media and cell extracts of the more aggressive PC-3 cell line contained more than two-fold greater PA activity than the relatively indolent DU-145 cell line. Zymographic studies identified the PA expressed as u-PA. PC-3 cells expressed an additional lower molecular weight form of u-PA not noted in DU-145 cells. Heterogeneity in u-PA expression was shown by the fibrin lysis assay, immunohistochemistry, and dual parameter flow cytometry indicating the presence of phenotypically divergent cell populations. Increased u-PA expression may identify those tumor cells that possess aggressive biological potential.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Flow Cytometry
  • Humans
  • Immunohistochemistry
  • Male
  • Neoplasm Invasiveness*
  • Neoplasm Metastasis
  • Plasminogen Activators / analysis*
  • Prostatic Neoplasms / enzymology*
  • Prostatic Neoplasms / pathology
  • Tumor Cells, Cultured
  • Urokinase-Type Plasminogen Activator / analysis

Substances

  • Plasminogen Activators
  • Urokinase-Type Plasminogen Activator